From conceptual design to study execution, data collection, data analysis and conclusion...
We transform your therapeutics developmental plan into 
an elegant reality

Beauty of Biology’   Principium to the discovery of modern therapeutics

PulchriBio | Preclinical Research for Nature-inspired Therapeutics

Clinical/Preclinical Services

We provide a wide range of clinical services and cell-based assays to help uncovering clinical implications of natural and synthetic therapeutic materials.  

News & Views

Read on for our blogs, and recent publications in peer-revised books and scientific journals.

In a Nutshell

  • Experted   Broad range of specialized biological investigation expertise
  • Creative | Dynamic   Work closely with you, design and execute scientific investigations unique to your objectives
  • Accessible   Scientific staff committed for high quality, prompt technical support
  • Dependable   Fast and reliable turnaround


Our Story

PulchriBio was founded in 2018 by a closely-knit network of clinical and preclinical investigators and experimentalists. With scientists from a broad range of specialized biological investigation disciplinaries, our team takes your therapeutics developmental goal to the next stage.


Anti-inflammatory bioassay

Latest from our blog

Sugar, alcohol, wine vs. health: are we at war or should we be friended?  So much have we heard about whether sugar is bad, or should it be cut completely off a healthy diet. Debate is also ongoing about alcohol, even wine (including red wine, regardless the common belief on red wine health.) What are we supposed to do? Here is more to understand before you make your judgement. Read more here.

Cell-based assay market analysis & forecast: Cell-based assays have the potential to deliver more information about intracellular molecular targets than conventional methods such as molecular manipulation and random screening. These assays are critical tools for studying cellular mechanisms in a biological context. According a market intelligence company, the global cell-based assay market is anticipated to surpass $10 billion by 2023, registering a CAGR of 16.5% from 2017 to 2023. Read more here.